1	3 subject whose seizure have be control for 12 week prior to start of the investigational product with a stable maintenance dose of vpa monotherapy 400-1200 mg/d|vpa[132,135]|||400 - 1200mg[148,159]||||12 week[44,51]|||1099703|40254|valproate
